Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of TranslationMohamed Rahmani, Steven Grant|Journal of Biological Chemistry|2005Cited by 284
Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple MyelomaAshraf Badros, Steven Grant|Clinical Cancer Research|2009Cited by 230
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Steven Grant|Blood|2004Cited by 123
The Bruton tyrosine kinase (<scp>BTK</scp>) inhibitor <scp>PCI</scp>‐32765 synergistically increases proteasome inhibitor activity in diffuse large‐B cell lymphoma (<scp>DLBCL</scp>) and mantle cell lymphoma (<scp>MCL</scp>) cells sensitive or resistant to bortezomibGirija Dasmahapatra, Steven Grant|British Journal of Haematology|2013Cited by 84
HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells <i>In Vitro</i> and <i>In Vivo</i>Tri Nguyen, Steven Grant|Clinical Cancer Research|2011Cited by 76